Literature DB >> 20200626

Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.

Mevlut Koc1, Osman Karaarslan, Gulcan Abali, Mustafa Kemal Batur.   

Abstract

Limited, controversial data exist regarding changes in high-sensitivity C-reactive protein (hs-CRP) levels over short times and the importance of detecting these changes in patients who have coronary artery disease (CAD). We investigated the variation of hs-CRP levels and their association with the severity of CAD in patients with stable CAD.We measured morning, midday, evening, and midnight hs-CRP levels in 124 patients (94 with CAD, 30 with normal coronary arteries), who were evaluated via coronary angiography and Gensini scoring. Patients were divided into 3 groups (normal coronary arteries, mild CAD, or severe CAD) according to Gensini score.Temporal hs-CRP levels varied significantly--the highest mean concentrations were found in the morning, and the lowest concentrations at midday (P <0.001). All temporal hs-CRP measurements and the absolute increase in hs-CRP levels were significantly higher in patients with severe CAD (both P <0.001). The most significant predictors of CAD severity were age (P=0.005), midday hs-CRP level (P <0.001), and brain natriuretic peptide level (P=0.045). Receiver operating characteristic curve analysis showed that cutoff values of hs-CRP taken at different times predicted severe CAD with similar sensitivity and specificity. Different cutoff values for temporal hs-CRP levels correlated with the severity of CAD. Serum levels of hs-CRP varied over 24 hours, whether patients had CAD or normal coronary arteries.

Entities:  

Keywords:  Analysis of variance; C-reactive protein/analysis; biological markers/ blood; coronary artery disease/blood; coronary stenosis; predictive value of tests; reference values; time factors

Mesh:

Substances:

Year:  2010        PMID: 20200626      PMCID: PMC2829811     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  19 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.

Authors:  H K Meier-Ewert; P M Ridker; N Rifai; N Price; D F Dinges; J M Mullington
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

3.  C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.

Authors:  James S Zebrack; Joseph B Muhlestein; Benjamin D Horne; Jeffrey L Anderson
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

6.  Natural history of ischemic heart disease in relation to arteriographic findings: a twelve year study of 224 patients.

Authors:  J O Humphries; L Kuller; R S Ross; G C Friesinger; E E Page
Journal:  Circulation       Date:  1974-03       Impact factor: 29.690

7.  C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris.

Authors:  M C Tataru; J Heinrich; R Junker; H Schulte; A von Eckardstein; G Assmann; E Koehler
Journal:  Eur Heart J       Date:  2000-06       Impact factor: 29.983

8.  A more meaningful scoring system for determining the severity of coronary heart disease.

Authors:  G G Gensini
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

9.  Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease.

Authors:  Ramón Arroyo-Espliguero; Pablo Avanzas; Juan Quiles; Juan Carlos Kaski
Journal:  Atherosclerosis       Date:  2008-08-15       Impact factor: 5.162

10.  Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina.

Authors:  Pablo Avanzas; Ramón Arroyo-Espliguero; Juan Cosín-Sales; Juan Quiles; Emmanouil Zouridakis; Juan Carlos Kaski
Journal:  Atherosclerosis       Date:  2004-07       Impact factor: 5.162

View more
  10 in total

1.  Inflammation, high-sensitivity C-reactive protein, and vascular protection.

Authors:  Paul M Ridker
Journal:  Tex Heart Inst J       Date:  2010

2.  Ramadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors.

Authors:  Ghada M A Ajabnoor; Suhad Bahijri; Noor Ahmad Shaik; Anwar Borai; Aliaa A Alamoudi; Jumana Y Al-Aama; George P Chrousos
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

3.  Assessing salivary C-reactive protein: longitudinal associations with systemic inflammation and cardiovascular disease risk in women exposed to intimate partner violence.

Authors:  Dorothée Out; Rosalie J Hall; Douglas A Granger; Gayle G Page; Stephanie J Woods
Journal:  Brain Behav Immun       Date:  2012-02-02       Impact factor: 7.217

4.  Psychiatric symptoms are not associated with circulating CRP concentrations after controlling for medical, social, and demographic factors.

Authors:  Jonathan Savitz; Martin P Paulus; Leandra K Figueroa-Hall; Bohan Xu; Rayus Kuplicki; Bart N Ford; Kaiping Burrows; T Kent Teague; Sandip Sen; Hung-Wen Yeh; Michael R Irwin
Journal:  Transl Psychiatry       Date:  2022-07-12       Impact factor: 7.989

5.  A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.

Authors:  Ming Dong; James K Liao; Bryan Yan; Ruijie Li; Mang Zhang; Cheuk-Man Yu
Journal:  Int J Cardiol       Date:  2012-08-24       Impact factor: 4.164

Review 6.  Interacting epidemics? Sleep curtailment, insulin resistance, and obesity.

Authors:  Eliane A Lucassen; Kristina I Rother; Giovanni Cizza
Journal:  Ann N Y Acad Sci       Date:  2012-07-24       Impact factor: 5.691

7.  The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis.

Authors:  Mohammad Assadpour Piranfar
Journal:  Int Cardiovasc Res J       Date:  2014-01-01

8.  Very Long (> 48 hours) Shifts and Cardiovascular Strain in Firefighters: a Theoretical Framework.

Authors:  Bongkyoo Choi; Peter L Schnall; Marnie Dobson; Javier Garcia-Rivas; Hyoungryoul Kim; Frank Zaldivar; Leslie Israel; Dean Baker
Journal:  Ann Occup Environ Med       Date:  2014-03-06

9.  The 7-Year Change in the Prevalence of Insulin Resistance, Inflammatory Biomarkers, and Their Determinants in an Urban South African Population.

Authors:  Saarah Fatoma Gadija Davids; Tandi Edith Matsha; Nasheeta Peer; Rajiv Timothy Erasmus; Andre Pascal Kengne
Journal:  J Diabetes Res       Date:  2020-05-20       Impact factor: 4.011

10.  The relationship between serum levels of hs-CRP and coronary lesion severity.

Authors:  Mohammad Mehdi Razban; Masoud Eslami; Ataollah Bagherzadeh
Journal:  Clujul Med       Date:  2016-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.